---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-002858"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2025-04-07T23:59:59+00:00"
generated_at: "2026-05-23T20:36:16.454940+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech receives NYSE American delisting notice for low stock price; plans appeal

## Summary
- Received notice on April 4, 2025 from NYSE American of suspension and delisting under Section 1003(f)(v) due to low selling price.
- Company will appeal the delisting determination to the Listing Qualifications Panel; no guarantee of success.
- Common stock expected to begin trading on the Pink Open Market on April 7, 2025.
- Trading on NYSE American has been suspended effective April 4, 2025.

## SEC filing metadata
- accession: 0001641172-25-002858
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2025-04-07T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000164117225002858/0001641172-25-002858-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000164117225002858/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-002858
- JSON: https://secwatch.observer/filing/0001641172-25-002858.json
- Plain text: https://secwatch.observer/filing/0001641172-25-002858.txt

## Key facts
- Listing & Compliance Notices
  AIM ImmunoTech Inc. received a nyse_american delisting notice notice regarding minimum bid price (rules 1003(f)(v)).
  - Exchange: nyse american
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 1003(f)(v)
  source text: April 4, 2025, AIM ImmunoTech Inc. (the “Company”) received notice from NYSE Regulation of the NYSE American LLC (“NYSE American”) that it had suspended trading of the Company’s common stock and determined to commence proceedings to delist the Company’s common stock from the NYSE American as a result of its determination that the Company is no longer suitable for listing pursuant to Section 1003(f)(v) of the NYSE American Company Guide due to the low selling price of the Company’s common stock. The Company has a right to a review of NYSE American’s determination to delist the Company’s common
  evidence_url: https://www.sec.gov/Archives/edgar/data/946644/000164117225002858/0001641172-25-002858-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.